The Roche Elecsys Syphilis assay is a diagnostic test offered by Roche Diagnostics. It is used for the qualitative detection of antibodies against Treponema pallidum, the bacterium that causes syphilis, in human serum or plasma samples.
The “100 Test” specification indicates that the kit contains enough reagents and supplies to perform 100 individual tests for syphilis. This allows for efficient testing in a clinical laboratory setting.
The Elecsys Syphilis assay utilizes an electrochemiluminescence immunoassay (ECLIA) technology. It is performed on Roche Elecsys immunoassay analyzers, which are automated systems used in clinical laboratories.
The Elecsys Syphilis assay provides reliable and accurate results for the screening and diagnosis of syphilis infection. It detects the presence of specific antibodies produced by the body in response to the bacterium. A positive result indicates the presence of syphilis antibodies, suggesting a current or past infection.
Syphilis is a sexually transmitted infection (STI) that can have serious health consequences if left untreated. Early detection and treatment are crucial to prevent complications. The Elecsys Syphilis assay aids in the identification of syphilis cases, allowing healthcare providers to initiate appropriate treatment and prevent transmission.
It’s important to note that the information provided is based on general knowledge, and there may have been updates or new versions of the product since my knowledge cutoff in September 2021. For the most accurate and up-to-date information, it’s recommended to refer to the product documentation or contact Roche Diagnostics directly.
